People-focused cancer care demands policy support
Access to high-quality cancer care remains deeply uneven worldwide. While advances in cancer treatment and diagnostics are improving survival rates…
Interviews
PrEP therapies offer new hope in HIV preventive landscape as vaccine failures amass
Will the tide turn for the wave of pharma layoffs?
Clinical research in the UK must build on industry collaboration, says NIHR director
How NVIDIA grew with the healthcare market instead of pushing into it
Drug development costs predicted to soar as BIOSECURE Act gains momentum
Boehringer Ingelheim plans sustainability work for the long term
Q&A: Cell and gene therapy value assessments need a rework to allow access
